nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC22A5—Dactinomycin—sarcoma	0.336	0.48	CbGbCtD
Amphetamine—SLC22A3—Vincristine—sarcoma	0.334	0.476	CbGbCtD
Amphetamine—CYP2D6—Doxorubicin—sarcoma	0.031	0.0442	CbGbCtD
Amphetamine—CARTPT—hematopoietic system—sarcoma	0.00808	0.085	CbGeAlD
Amphetamine—CARTPT—connective tissue—sarcoma	0.00778	0.0818	CbGeAlD
Amphetamine—Stomach ache—Mitoxantrone—sarcoma	0.00606	0.0303	CcSEcCtD
Amphetamine—Cardiomyopathy—Thiotepa—sarcoma	0.00583	0.0292	CcSEcCtD
Amphetamine—CARTPT—lymphoid tissue—sarcoma	0.00569	0.0598	CbGeAlD
Amphetamine—Cardiomyopathy—Mitoxantrone—sarcoma	0.00503	0.0252	CcSEcCtD
Amphetamine—Sudden death—Mitoxantrone—sarcoma	0.00503	0.0252	CcSEcCtD
Amphetamine—CARTPT—testis—sarcoma	0.00443	0.0466	CbGeAlD
Amphetamine—Pseudoephedrine—IL2—sarcoma	0.00405	1	CrCbGaD
Amphetamine—CARTPT—lymph node—sarcoma	0.00321	0.0338	CbGeAlD
Amphetamine—Viral infection—Mitoxantrone—sarcoma	0.00285	0.0143	CcSEcCtD
Amphetamine—SLC18A2—hematopoietic system—sarcoma	0.00274	0.0289	CbGeAlD
Amphetamine—CYP2A6—seminal vesicle—sarcoma	0.00258	0.0271	CbGeAlD
Amphetamine—Cardiomyopathy—Epirubicin—sarcoma	0.00235	0.0118	CcSEcCtD
Amphetamine—SLC22A5—mammary gland—sarcoma	0.00233	0.0245	CbGeAlD
Amphetamine—SLC22A3—myometrium—sarcoma	0.00228	0.024	CbGeAlD
Amphetamine—SLC22A3—embryo—sarcoma	0.00219	0.023	CbGeAlD
Amphetamine—Cardiomyopathy—Doxorubicin—sarcoma	0.00217	0.0109	CcSEcCtD
Amphetamine—MAOB—myometrium—sarcoma	0.00211	0.0222	CbGeAlD
Amphetamine—SLC6A3—hematopoietic system—sarcoma	0.00208	0.0218	CbGeAlD
Amphetamine—SLC18A2—uterus—sarcoma	0.00207	0.0218	CbGeAlD
Amphetamine—SLC22A3—seminal vesicle—sarcoma	0.00206	0.0216	CbGeAlD
Amphetamine—MAOB—embryo—sarcoma	0.00203	0.0213	CbGeAlD
Amphetamine—SLC22A3—hematopoietic system—sarcoma	0.00195	0.0206	CbGeAlD
Amphetamine—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00193	0.00969	CcSEcCtD
Amphetamine—MAOB—seminal vesicle—sarcoma	0.0019	0.02	CbGeAlD
Amphetamine—SLC6A4—hematopoietic system—sarcoma	0.0019	0.02	CbGeAlD
Amphetamine—SLC22A3—connective tissue—sarcoma	0.00188	0.0198	CbGeAlD
Amphetamine—SLC18A2—tendon—sarcoma	0.00182	0.0191	CbGeAlD
Amphetamine—MAOB—hematopoietic system—sarcoma	0.00181	0.019	CbGeAlD
Amphetamine—MAOB—connective tissue—sarcoma	0.00174	0.0183	CbGeAlD
Amphetamine—SLC22A3—smooth muscle tissue—sarcoma	0.00172	0.0181	CbGeAlD
Amphetamine—Abdominal pain upper—Mitoxantrone—sarcoma	0.00171	0.00855	CcSEcCtD
Amphetamine—SLC22A5—myometrium—sarcoma	0.00166	0.0174	CbGeAlD
Amphetamine—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00164	0.00822	CcSEcCtD
Amphetamine—Erectile dysfunction—Vincristine—sarcoma	0.00153	0.00765	CcSEcCtD
Amphetamine—Photosensitivity reaction—Vincristine—sarcoma	0.00151	0.00758	CcSEcCtD
Amphetamine—SLC18A2—testis—sarcoma	0.0015	0.0158	CbGeAlD
Amphetamine—Weight decreased—Vincristine—sarcoma	0.0015	0.00752	CcSEcCtD
Amphetamine—SLC22A5—seminal vesicle—sarcoma	0.0015	0.0157	CbGeAlD
Amphetamine—Erectile dysfunction—Mitoxantrone—sarcoma	0.00149	0.00745	CcSEcCtD
Amphetamine—Depression—Vincristine—sarcoma	0.00148	0.00739	CcSEcCtD
Amphetamine—Weight decreased—Mitoxantrone—sarcoma	0.00146	0.00732	CcSEcCtD
Amphetamine—Acute coronary syndrome—Vincristine—sarcoma	0.00146	0.0073	CcSEcCtD
Amphetamine—Myocardial infarction—Vincristine—sarcoma	0.00145	0.00726	CcSEcCtD
Amphetamine—SLC18A2—liver—sarcoma	0.00142	0.015	CbGeAlD
Amphetamine—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00142	0.00711	CcSEcCtD
Amphetamine—Sweating—Vincristine—sarcoma	0.00142	0.0071	CcSEcCtD
Amphetamine—Myocardial infarction—Mitoxantrone—sarcoma	0.00141	0.00707	CcSEcCtD
Amphetamine—Erythema multiforme—Dactinomycin—sarcoma	0.00141	0.00704	CcSEcCtD
Amphetamine—Urinary tract infection—Mitoxantrone—sarcoma	0.0014	0.00701	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Etoposide—sarcoma	0.0014	0.00701	CcSEcCtD
Amphetamine—Sweating—Mitoxantrone—sarcoma	0.00138	0.00692	CcSEcCtD
Amphetamine—MAOB—cardiac atrium—sarcoma	0.00137	0.0145	CbGeAlD
Amphetamine—MAOB—uterus—sarcoma	0.00137	0.0144	CbGeAlD
Amphetamine—Viral infection—Epirubicin—sarcoma	0.00133	0.00666	CcSEcCtD
Amphetamine—Tension—Thiotepa—sarcoma	0.00128	0.00641	CcSEcCtD
Amphetamine—Dyskinesia—Epirubicin—sarcoma	0.00128	0.0064	CcSEcCtD
Amphetamine—CYP2A6—liver—sarcoma	0.00127	0.0134	CbGeAlD
Amphetamine—Nervousness—Thiotepa—sarcoma	0.00127	0.00634	CcSEcCtD
Amphetamine—SLC22A5—skin of body—sarcoma	0.00124	0.013	CbGeAlD
Amphetamine—Viral infection—Doxorubicin—sarcoma	0.00123	0.00616	CcSEcCtD
Amphetamine—Agitation—Thiotepa—sarcoma	0.0012	0.006	CcSEcCtD
Amphetamine—MAOB—tendon—sarcoma	0.0012	0.0126	CbGeAlD
Amphetamine—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00119	0.00595	CcSEcCtD
Amphetamine—Dyskinesia—Doxorubicin—sarcoma	0.00118	0.00592	CcSEcCtD
Amphetamine—Acute coronary syndrome—Etoposide—sarcoma	0.00118	0.00592	CcSEcCtD
Amphetamine—Myocardial infarction—Etoposide—sarcoma	0.00117	0.00588	CcSEcCtD
Amphetamine—SLC6A3—testis—sarcoma	0.00114	0.012	CbGeAlD
Amphetamine—Convulsion—Thiotepa—sarcoma	0.00113	0.00566	CcSEcCtD
Amphetamine—Hypertension—Thiotepa—sarcoma	0.00113	0.00564	CcSEcCtD
Amphetamine—Anxiety—Thiotepa—sarcoma	0.00111	0.00554	CcSEcCtD
Amphetamine—SLC18A2—lymph node—sarcoma	0.00109	0.0115	CbGeAlD
Amphetamine—SLC22A5—cardiac atrium—sarcoma	0.00108	0.0114	CbGeAlD
Amphetamine—SLC22A3—testis—sarcoma	0.00107	0.0113	CbGeAlD
Amphetamine—Agitation—Vincristine—sarcoma	0.00106	0.00532	CcSEcCtD
Amphetamine—Infection—Thiotepa—sarcoma	0.00106	0.00529	CcSEcCtD
Amphetamine—Infection—Dactinomycin—sarcoma	0.00105	0.00525	CcSEcCtD
Amphetamine—Tachycardia—Thiotepa—sarcoma	0.00104	0.0052	CcSEcCtD
Amphetamine—Erythema multiforme—Etoposide—sarcoma	0.00102	0.00509	CcSEcCtD
Amphetamine—Anorexia—Thiotepa—sarcoma	0.00101	0.00508	CcSEcCtD
Amphetamine—SLC22A3—liver—sarcoma	0.00101	0.0107	CbGeAlD
Amphetamine—Anorexia—Dactinomycin—sarcoma	0.00101	0.00504	CcSEcCtD
Amphetamine—Convulsion—Vincristine—sarcoma	0.001	0.00502	CcSEcCtD
Amphetamine—Hypertension—Vincristine—sarcoma	0.000998	0.005	CcSEcCtD
Amphetamine—MAOB—testis—sarcoma	0.000991	0.0104	CbGeAlD
Amphetamine—Convulsion—Mitoxantrone—sarcoma	0.000975	0.00488	CcSEcCtD
Amphetamine—Hypertension—Mitoxantrone—sarcoma	0.000972	0.00487	CcSEcCtD
Amphetamine—Chest pain—Mitoxantrone—sarcoma	0.000959	0.0048	CcSEcCtD
Amphetamine—Anxiety—Mitoxantrone—sarcoma	0.000955	0.00478	CcSEcCtD
Amphetamine—Somnolence—Thiotepa—sarcoma	0.000946	0.00474	CcSEcCtD
Amphetamine—Anaphylactic shock—Vincristine—sarcoma	0.000944	0.00472	CcSEcCtD
Amphetamine—SLC22A5—tendon—sarcoma	0.000941	0.0099	CbGeAlD
Amphetamine—Infection—Vincristine—sarcoma	0.000937	0.00469	CcSEcCtD
Amphetamine—MAOB—liver—sarcoma	0.000937	0.00986	CbGeAlD
Amphetamine—Dyspepsia—Thiotepa—sarcoma	0.000937	0.00469	CcSEcCtD
Amphetamine—Decreased appetite—Thiotepa—sarcoma	0.000925	0.00463	CcSEcCtD
Amphetamine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000919	0.0046	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000919	0.0046	CcSEcCtD
Amphetamine—Decreased appetite—Dactinomycin—sarcoma	0.000918	0.0046	CcSEcCtD
Amphetamine—SLC6A2—testis—sarcoma	0.000918	0.00966	CbGeAlD
Amphetamine—Fatigue—Thiotepa—sarcoma	0.000917	0.00459	CcSEcCtD
Amphetamine—CYP2D6—hematopoietic system—sarcoma	0.000917	0.00965	CbGeAlD
Amphetamine—Infection—Mitoxantrone—sarcoma	0.000913	0.00457	CcSEcCtD
Amphetamine—Hyperhidrosis—Vincristine—sarcoma	0.000912	0.00457	CcSEcCtD
Amphetamine—Fatigue—Dactinomycin—sarcoma	0.00091	0.00456	CcSEcCtD
Amphetamine—Constipation—Thiotepa—sarcoma	0.00091	0.00456	CcSEcCtD
Amphetamine—Anorexia—Vincristine—sarcoma	0.000899	0.0045	CcSEcCtD
Amphetamine—Tachycardia—Mitoxantrone—sarcoma	0.000897	0.00449	CcSEcCtD
Amphetamine—Cerebrovascular accident—Epirubicin—sarcoma	0.00089	0.00445	CcSEcCtD
Amphetamine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000888	0.00445	CcSEcCtD
Amphetamine—Anorexia—Mitoxantrone—sarcoma	0.000876	0.00439	CcSEcCtD
Amphetamine—Gastrointestinal pain—Thiotepa—sarcoma	0.00087	0.00436	CcSEcCtD
Amphetamine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000864	0.00432	CcSEcCtD
Amphetamine—Affect lability—Epirubicin—sarcoma	0.000858	0.0043	CcSEcCtD
Amphetamine—Insomnia—Vincristine—sarcoma	0.000853	0.00427	CcSEcCtD
Amphetamine—Urticaria—Thiotepa—sarcoma	0.000845	0.00423	CcSEcCtD
Amphetamine—Body temperature increased—Thiotepa—sarcoma	0.000841	0.00421	CcSEcCtD
Amphetamine—Abdominal pain—Thiotepa—sarcoma	0.000841	0.00421	CcSEcCtD
Amphetamine—DRD2—testis—sarcoma	0.000836	0.0088	CbGeAlD
Amphetamine—Body temperature increased—Dactinomycin—sarcoma	0.000835	0.00418	CcSEcCtD
Amphetamine—Abdominal pain—Dactinomycin—sarcoma	0.000835	0.00418	CcSEcCtD
Amphetamine—Mood swings—Epirubicin—sarcoma	0.000826	0.00414	CcSEcCtD
Amphetamine—Cerebrovascular accident—Doxorubicin—sarcoma	0.000823	0.00412	CcSEcCtD
Amphetamine—Decreased appetite—Vincristine—sarcoma	0.00082	0.00411	CcSEcCtD
Amphetamine—Dyspnoea—Mitoxantrone—sarcoma	0.000819	0.0041	CcSEcCtD
Amphetamine—Somnolence—Mitoxantrone—sarcoma	0.000817	0.00409	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Vincristine—sarcoma	0.000815	0.00408	CcSEcCtD
Amphetamine—Fatigue—Vincristine—sarcoma	0.000813	0.00407	CcSEcCtD
Amphetamine—Convulsion—Etoposide—sarcoma	0.000811	0.00406	CcSEcCtD
Amphetamine—Dyspepsia—Mitoxantrone—sarcoma	0.000809	0.00405	CcSEcCtD
Amphetamine—Hypertension—Etoposide—sarcoma	0.000809	0.00405	CcSEcCtD
Amphetamine—Constipation—Vincristine—sarcoma	0.000807	0.00404	CcSEcCtD
Amphetamine—Decreased appetite—Mitoxantrone—sarcoma	0.000799	0.004	CcSEcCtD
Amphetamine—Chest pain—Etoposide—sarcoma	0.000797	0.00399	CcSEcCtD
Amphetamine—Abdominal pain upper—Epirubicin—sarcoma	0.000796	0.00399	CcSEcCtD
Amphetamine—Affect lability—Doxorubicin—sarcoma	0.000794	0.00398	CcSEcCtD
Amphetamine—Fatigue—Mitoxantrone—sarcoma	0.000792	0.00397	CcSEcCtD
Amphetamine—Constipation—Mitoxantrone—sarcoma	0.000786	0.00393	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000785	0.00393	CcSEcCtD
Amphetamine—Hypersensitivity—Thiotepa—sarcoma	0.000784	0.00393	CcSEcCtD
Amphetamine—SLC22A5—testis—sarcoma	0.000779	0.0082	CbGeAlD
Amphetamine—Hypersensitivity—Dactinomycin—sarcoma	0.000778	0.0039	CcSEcCtD
Amphetamine—SLC22A3—lymph node—sarcoma	0.000776	0.00817	CbGeAlD
Amphetamine—Gastrointestinal pain—Vincristine—sarcoma	0.000772	0.00386	CcSEcCtD
Amphetamine—Anaphylactic shock—Etoposide—sarcoma	0.000764	0.00383	CcSEcCtD
Amphetamine—Mood swings—Doxorubicin—sarcoma	0.000764	0.00383	CcSEcCtD
Amphetamine—Asthenia—Thiotepa—sarcoma	0.000763	0.00382	CcSEcCtD
Amphetamine—Infection—Etoposide—sarcoma	0.000759	0.0038	CcSEcCtD
Amphetamine—Asthenia—Dactinomycin—sarcoma	0.000758	0.00379	CcSEcCtD
Amphetamine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000751	0.00376	CcSEcCtD
Amphetamine—Tachycardia—Etoposide—sarcoma	0.000746	0.00374	CcSEcCtD
Amphetamine—Abdominal pain—Vincristine—sarcoma	0.000746	0.00373	CcSEcCtD
Amphetamine—Body temperature increased—Vincristine—sarcoma	0.000746	0.00373	CcSEcCtD
Amphetamine—Hyperhidrosis—Etoposide—sarcoma	0.000739	0.0037	CcSEcCtD
Amphetamine—Abdominal pain upper—Doxorubicin—sarcoma	0.000737	0.00369	CcSEcCtD
Amphetamine—SLC22A5—liver—sarcoma	0.000736	0.00775	CbGeAlD
Amphetamine—Urticaria—Mitoxantrone—sarcoma	0.00073	0.00366	CcSEcCtD
Amphetamine—Anorexia—Etoposide—sarcoma	0.000729	0.00365	CcSEcCtD
Amphetamine—Diarrhoea—Thiotepa—sarcoma	0.000728	0.00365	CcSEcCtD
Amphetamine—Abdominal pain—Mitoxantrone—sarcoma	0.000726	0.00364	CcSEcCtD
Amphetamine—Body temperature increased—Mitoxantrone—sarcoma	0.000726	0.00364	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000726	0.00364	CcSEcCtD
Amphetamine—Diarrhoea—Dactinomycin—sarcoma	0.000723	0.00362	CcSEcCtD
Amphetamine—MAOB—lymph node—sarcoma	0.000719	0.00756	CbGeAlD
Amphetamine—Dizziness—Thiotepa—sarcoma	0.000704	0.00352	CcSEcCtD
Amphetamine—Hypersensitivity—Vincristine—sarcoma	0.000695	0.00348	CcSEcCtD
Amphetamine—Photosensitivity reaction—Epirubicin—sarcoma	0.000688	0.00344	CcSEcCtD
Amphetamine—Weight decreased—Epirubicin—sarcoma	0.000682	0.00341	CcSEcCtD
Amphetamine—Dyspnoea—Etoposide—sarcoma	0.000681	0.00341	CcSEcCtD
Amphetamine—Somnolence—Etoposide—sarcoma	0.000679	0.0034	CcSEcCtD
Amphetamine—Hypersensitivity—Mitoxantrone—sarcoma	0.000677	0.00339	CcSEcCtD
Amphetamine—Asthenia—Vincristine—sarcoma	0.000677	0.00339	CcSEcCtD
Amphetamine—Vomiting—Thiotepa—sarcoma	0.000677	0.00339	CcSEcCtD
Amphetamine—Vomiting—Dactinomycin—sarcoma	0.000671	0.00336	CcSEcCtD
Amphetamine—Rash—Thiotepa—sarcoma	0.000671	0.00336	CcSEcCtD
Amphetamine—Dermatitis—Thiotepa—sarcoma	0.00067	0.00336	CcSEcCtD
Amphetamine—Headache—Thiotepa—sarcoma	0.000667	0.00334	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000666	0.00333	CcSEcCtD
Amphetamine—Rash—Dactinomycin—sarcoma	0.000666	0.00333	CcSEcCtD
Amphetamine—SLC6A2—lymph node—sarcoma	0.000665	0.007	CbGeAlD
Amphetamine—Decreased appetite—Etoposide—sarcoma	0.000664	0.00333	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Etoposide—sarcoma	0.00066	0.0033	CcSEcCtD
Amphetamine—Asthenia—Mitoxantrone—sarcoma	0.000659	0.0033	CcSEcCtD
Amphetamine—Fatigue—Etoposide—sarcoma	0.000659	0.0033	CcSEcCtD
Amphetamine—Constipation—Etoposide—sarcoma	0.000654	0.00327	CcSEcCtD
Amphetamine—Urinary tract infection—Epirubicin—sarcoma	0.000653	0.00327	CcSEcCtD
Amphetamine—Diarrhoea—Vincristine—sarcoma	0.000646	0.00323	CcSEcCtD
Amphetamine—Sweating—Epirubicin—sarcoma	0.000644	0.00322	CcSEcCtD
Amphetamine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000636	0.00319	CcSEcCtD
Amphetamine—Nausea—Thiotepa—sarcoma	0.000632	0.00316	CcSEcCtD
Amphetamine—Weight decreased—Doxorubicin—sarcoma	0.000631	0.00316	CcSEcCtD
Amphetamine—Diarrhoea—Mitoxantrone—sarcoma	0.000629	0.00315	CcSEcCtD
Amphetamine—Nausea—Dactinomycin—sarcoma	0.000627	0.00314	CcSEcCtD
Amphetamine—Gastrointestinal pain—Etoposide—sarcoma	0.000625	0.00313	CcSEcCtD
Amphetamine—Dizziness—Vincristine—sarcoma	0.000624	0.00312	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000616	0.00309	CcSEcCtD
Amphetamine—Urticaria—Etoposide—sarcoma	0.000607	0.00304	CcSEcCtD
Amphetamine—Abdominal pain—Etoposide—sarcoma	0.000604	0.00303	CcSEcCtD
Amphetamine—Body temperature increased—Etoposide—sarcoma	0.000604	0.00303	CcSEcCtD
Amphetamine—Urinary tract infection—Doxorubicin—sarcoma	0.000604	0.00303	CcSEcCtD
Amphetamine—Vomiting—Vincristine—sarcoma	0.0006	0.003	CcSEcCtD
Amphetamine—Sweating—Doxorubicin—sarcoma	0.000596	0.00298	CcSEcCtD
Amphetamine—Rash—Vincristine—sarcoma	0.000595	0.00298	CcSEcCtD
Amphetamine—Dermatitis—Vincristine—sarcoma	0.000594	0.00298	CcSEcCtD
Amphetamine—Headache—Vincristine—sarcoma	0.000591	0.00296	CcSEcCtD
Amphetamine—Vomiting—Mitoxantrone—sarcoma	0.000584	0.00293	CcSEcCtD
Amphetamine—Rash—Mitoxantrone—sarcoma	0.000579	0.0029	CcSEcCtD
Amphetamine—Dermatitis—Mitoxantrone—sarcoma	0.000579	0.0029	CcSEcCtD
Amphetamine—Headache—Mitoxantrone—sarcoma	0.000576	0.00288	CcSEcCtD
Amphetamine—Erythema multiforme—Epirubicin—sarcoma	0.00057	0.00286	CcSEcCtD
Amphetamine—SLC22A5—lymph node—sarcoma	0.000565	0.00594	CbGeAlD
Amphetamine—Hypersensitivity—Etoposide—sarcoma	0.000563	0.00282	CcSEcCtD
Amphetamine—Nausea—Vincristine—sarcoma	0.00056	0.00281	CcSEcCtD
Amphetamine—Asthenia—Etoposide—sarcoma	0.000548	0.00275	CcSEcCtD
Amphetamine—Nausea—Mitoxantrone—sarcoma	0.000546	0.00273	CcSEcCtD
Amphetamine—Erythema multiforme—Doxorubicin—sarcoma	0.000528	0.00264	CcSEcCtD
Amphetamine—Diarrhoea—Etoposide—sarcoma	0.000523	0.00262	CcSEcCtD
Amphetamine—Tension—Epirubicin—sarcoma	0.000515	0.00258	CcSEcCtD
Amphetamine—Nervousness—Epirubicin—sarcoma	0.00051	0.00255	CcSEcCtD
Amphetamine—Dizziness—Etoposide—sarcoma	0.000505	0.00253	CcSEcCtD
Amphetamine—CYP2D6—testis—sarcoma	0.000503	0.00529	CbGeAlD
Amphetamine—Vomiting—Etoposide—sarcoma	0.000486	0.00243	CcSEcCtD
Amphetamine—Agitation—Epirubicin—sarcoma	0.000482	0.00242	CcSEcCtD
Amphetamine—Rash—Etoposide—sarcoma	0.000482	0.00241	CcSEcCtD
Amphetamine—Dermatitis—Etoposide—sarcoma	0.000481	0.00241	CcSEcCtD
Amphetamine—Headache—Etoposide—sarcoma	0.000479	0.0024	CcSEcCtD
Amphetamine—Tension—Doxorubicin—sarcoma	0.000477	0.00239	CcSEcCtD
Amphetamine—CYP2D6—liver—sarcoma	0.000475	0.005	CbGeAlD
Amphetamine—Nervousness—Doxorubicin—sarcoma	0.000472	0.00236	CcSEcCtD
Amphetamine—Palpitations—Epirubicin—sarcoma	0.000464	0.00232	CcSEcCtD
Amphetamine—Convulsion—Epirubicin—sarcoma	0.000455	0.00228	CcSEcCtD
Amphetamine—Nausea—Etoposide—sarcoma	0.000454	0.00227	CcSEcCtD
Amphetamine—Hypertension—Epirubicin—sarcoma	0.000453	0.00227	CcSEcCtD
Amphetamine—Chest pain—Epirubicin—sarcoma	0.000447	0.00224	CcSEcCtD
Amphetamine—Agitation—Doxorubicin—sarcoma	0.000446	0.00224	CcSEcCtD
Amphetamine—Anxiety—Epirubicin—sarcoma	0.000445	0.00223	CcSEcCtD
Amphetamine—Dry mouth—Epirubicin—sarcoma	0.000437	0.00219	CcSEcCtD
Amphetamine—Palpitations—Doxorubicin—sarcoma	0.000429	0.00215	CcSEcCtD
Amphetamine—Anaphylactic shock—Epirubicin—sarcoma	0.000428	0.00215	CcSEcCtD
Amphetamine—Infection—Epirubicin—sarcoma	0.000426	0.00213	CcSEcCtD
Amphetamine—Convulsion—Doxorubicin—sarcoma	0.000421	0.00211	CcSEcCtD
Amphetamine—Hypertension—Doxorubicin—sarcoma	0.000419	0.0021	CcSEcCtD
Amphetamine—Tachycardia—Epirubicin—sarcoma	0.000418	0.00209	CcSEcCtD
Amphetamine—Hyperhidrosis—Epirubicin—sarcoma	0.000414	0.00207	CcSEcCtD
Amphetamine—Chest pain—Doxorubicin—sarcoma	0.000414	0.00207	CcSEcCtD
Amphetamine—Anxiety—Doxorubicin—sarcoma	0.000412	0.00206	CcSEcCtD
Amphetamine—Anorexia—Epirubicin—sarcoma	0.000408	0.00205	CcSEcCtD
Amphetamine—Dry mouth—Doxorubicin—sarcoma	0.000404	0.00203	CcSEcCtD
Amphetamine—Anaphylactic shock—Doxorubicin—sarcoma	0.000396	0.00199	CcSEcCtD
Amphetamine—Infection—Doxorubicin—sarcoma	0.000394	0.00197	CcSEcCtD
Amphetamine—Insomnia—Epirubicin—sarcoma	0.000387	0.00194	CcSEcCtD
Amphetamine—Tachycardia—Doxorubicin—sarcoma	0.000387	0.00194	CcSEcCtD
Amphetamine—Hyperhidrosis—Doxorubicin—sarcoma	0.000383	0.00192	CcSEcCtD
Amphetamine—Dyspnoea—Epirubicin—sarcoma	0.000382	0.00191	CcSEcCtD
Amphetamine—Somnolence—Epirubicin—sarcoma	0.000381	0.00191	CcSEcCtD
Amphetamine—Anorexia—Doxorubicin—sarcoma	0.000378	0.00189	CcSEcCtD
Amphetamine—Dyspepsia—Epirubicin—sarcoma	0.000377	0.00189	CcSEcCtD
Amphetamine—Decreased appetite—Epirubicin—sarcoma	0.000372	0.00186	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Epirubicin—sarcoma	0.00037	0.00185	CcSEcCtD
Amphetamine—Fatigue—Epirubicin—sarcoma	0.000369	0.00185	CcSEcCtD
Amphetamine—Constipation—Epirubicin—sarcoma	0.000366	0.00183	CcSEcCtD
Amphetamine—Insomnia—Doxorubicin—sarcoma	0.000359	0.0018	CcSEcCtD
Amphetamine—Dyspnoea—Doxorubicin—sarcoma	0.000353	0.00177	CcSEcCtD
Amphetamine—Somnolence—Doxorubicin—sarcoma	0.000352	0.00176	CcSEcCtD
Amphetamine—Gastrointestinal pain—Epirubicin—sarcoma	0.00035	0.00175	CcSEcCtD
Amphetamine—Dyspepsia—Doxorubicin—sarcoma	0.000349	0.00175	CcSEcCtD
Amphetamine—Decreased appetite—Doxorubicin—sarcoma	0.000345	0.00173	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000342	0.00171	CcSEcCtD
Amphetamine—Fatigue—Doxorubicin—sarcoma	0.000342	0.00171	CcSEcCtD
Amphetamine—Urticaria—Epirubicin—sarcoma	0.00034	0.0017	CcSEcCtD
Amphetamine—Constipation—Doxorubicin—sarcoma	0.000339	0.0017	CcSEcCtD
Amphetamine—Abdominal pain—Epirubicin—sarcoma	0.000339	0.0017	CcSEcCtD
Amphetamine—Body temperature increased—Epirubicin—sarcoma	0.000339	0.0017	CcSEcCtD
Amphetamine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000324	0.00162	CcSEcCtD
Amphetamine—Hypersensitivity—Epirubicin—sarcoma	0.000316	0.00158	CcSEcCtD
Amphetamine—Urticaria—Doxorubicin—sarcoma	0.000315	0.00158	CcSEcCtD
Amphetamine—Abdominal pain—Doxorubicin—sarcoma	0.000313	0.00157	CcSEcCtD
Amphetamine—Body temperature increased—Doxorubicin—sarcoma	0.000313	0.00157	CcSEcCtD
Amphetamine—Asthenia—Epirubicin—sarcoma	0.000307	0.00154	CcSEcCtD
Amphetamine—Diarrhoea—Epirubicin—sarcoma	0.000293	0.00147	CcSEcCtD
Amphetamine—Hypersensitivity—Doxorubicin—sarcoma	0.000292	0.00146	CcSEcCtD
Amphetamine—Asthenia—Doxorubicin—sarcoma	0.000284	0.00142	CcSEcCtD
Amphetamine—Dizziness—Epirubicin—sarcoma	0.000283	0.00142	CcSEcCtD
Amphetamine—Vomiting—Epirubicin—sarcoma	0.000272	0.00136	CcSEcCtD
Amphetamine—Diarrhoea—Doxorubicin—sarcoma	0.000271	0.00136	CcSEcCtD
Amphetamine—Rash—Epirubicin—sarcoma	0.00027	0.00135	CcSEcCtD
Amphetamine—Dermatitis—Epirubicin—sarcoma	0.00027	0.00135	CcSEcCtD
Amphetamine—Headache—Epirubicin—sarcoma	0.000268	0.00134	CcSEcCtD
Amphetamine—Dizziness—Doxorubicin—sarcoma	0.000262	0.00131	CcSEcCtD
Amphetamine—Nausea—Epirubicin—sarcoma	0.000254	0.00127	CcSEcCtD
Amphetamine—Vomiting—Doxorubicin—sarcoma	0.000252	0.00126	CcSEcCtD
Amphetamine—Rash—Doxorubicin—sarcoma	0.00025	0.00125	CcSEcCtD
Amphetamine—Dermatitis—Doxorubicin—sarcoma	0.00025	0.00125	CcSEcCtD
Amphetamine—Headache—Doxorubicin—sarcoma	0.000248	0.00124	CcSEcCtD
Amphetamine—Nausea—Doxorubicin—sarcoma	0.000235	0.00118	CcSEcCtD
